Capitalizing Life Science Innovations


Allele Capital serves its clients in one of three ways – as an advisor, merchant bank and/or investment bank through its executing Broker-Dealer. Often our clients partner with us on two or more of these value-added services. Generally (but not always), our long-term client relationships begin with advisory work.

home icon 01 advisory

We partner as an extension of the management team to radically accelerate success. We start by understanding our client’s overall objectives and collaborate to define, refine and strengthen their business strategy to optimize milestones, capital needs, and capital markets objectives to maximize shareholder value. We draw on our decades of experience in capital formation and strategy to optimize capital structure and transactions needed to reach our clients’ desired outcomes. ​

home icon 02 merchant banking
Merchant Banking​

We leverage our sector expertise to identify promising private and small-cap public life science companies with exceptional management teams, disruptive platforms and the ability to achieve value milestones and liquidity within 12-24 months from initial investment. We source, structure and invest alongside our institutional and accredited investor network while aligning with our merchant banking clients’ business objectives.

home icon 03 investment banking
Investment Banking​

Facilitating through our executing broker-dealer, Wilmington Capital Securities, LLC, members FINRA and SIPC, we arrange cross-over financings, private placements, initial public offerings and secondary offerings. In addition to conducting sole placements, we have built trusted relationships with other investment banks to facilitate value-added syndication and capital markets support both pre and post transaction. ​